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Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by 
deficits in social interaction, difficulties with language, and repetitive/restricted behaviors. 
The etiology of ASD is still largely unclear, but immune dysfunction and abnormalities in 
synaptogenesis have repeatedly been implicated as contributing to the disease phe-
notype. However, an understanding of how and if these two processes are related has 
not firmly been established. As non-inflammatory roles of microglia become increasingly 
recognized as critical to normal neurodevelopment, it is important to consider how dys-
function in these processes might explain the seemingly disparate findings of immune 
dysfunction and aberrant synaptogenesis seen in ASD. In this review, we highlight 
research demonstrating the importance of microglia to the development of normal neural 
networks, review recent studies demonstrating abnormal microglia in autism, and dis-
cuss how the relationship between these processes may contribute to the development 
of autism and other neurodevelopmental disorders at the cellular level.
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introdUCtion
Autism spectrum disorder (ASD) is a clinical neurodevelopmental syndrome characterized by 
abnormalities in social interaction and language, and restrictive/repetitive patterns of interest (1). 
Despite the large and seemingly increasing prevalence of ASD (2), the biological mechanisms under-
lying the broad ASD phenotype remain unclear. However, strong evidence has recently implicated 
both immune pathways and independently, abnormalities in neural synaptogenesis, as potentially 
underlying the clinical ASD phenotype. However, it is unclear how these two seemingly distinct 
processes are related to the risk for the development of autism. A large body of research has sug-
gested a link between inflammation in the CNS and resultant destruction of neural networks as one 
potential link between these two processes (3). However, microglia – the resident immune cells of the 
CNS – are increasingly implicated in normal neurogenesis and the formation of neural networks in 
the unaffected developing brain (4–6). Furthermore, microglia have also been repeatedly shown to be 
abnormal in postmortem autistic brain tissue and cellular/animal models of ASD (7–10). Therefore, 
it is equally likely that inherent abnormalities in microglia that are required to properly shape devel-
oping neural networks may link these two seemingly disparate processes separate from microglia’s 
traditional role as immune cells (Figure  1). In this review, we highlight research demonstrating 
the importance of microglia to the development of normal neural networks, review recent studies 
demonstrating abnormal immune signaling and microglia in ASD, and discuss how the relationship 
FiGUre 1 | schematic representation of hypothesized non-immune microglial contributions to asd, as described in the text. It is proposed that 
inherited defects in the microglial genome/epigenome in autistic patients (center) result in abnormal or exaggerated execution of normal developmental microglial 
functions, such as (a) abnormal secretion of trophic factors necessary for normal neuronal growth, (B) incorrect synaptic pruning, (C) failure of appropriate 
apoptosis of neurons, and (d) exaggerated activation and cytokine secretion.
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between these two emerging areas of neurodevelopment research 
may at least partially contribute to the development of ASDs at 
the cellular level.
disCUssion
Microglia in normal neurodevelopment
The microglial cells of the CNS derive from myeloid progenitor 
cells in the yolk sac in early gestation, and travel to the brain 
to establish residency by early embryonic development (11). 
Traditionally, cellular neuroscience research has considered glial 
cells as predominately supportive to neurons during normal 
neurogenesis. In particular, microglia were traditionally viewed 
very narrowly as only becoming activated in response to patho-
logical insults, similar to their peripheral tissue counterparts, and 
thus contributing little to normal neurodevelopmental processes 
(12–14). However, in  vivo imaging techniques have repeatedly 
demonstrated that microglia are highly active during normal 
brain development and that they interact directly with neurons 
during critical period of neurogenesis (4, 5). Moreover, activity-
dependent synapse and dendritic spine remodeling have been 
shown to be modulated in part by microglia in the mouse motor 
cortex and visual cortex (6). These and similar findings have 
helped to shift the view of normal cellular neurodevelopment 
from a primarily neuroncentric process to one that acknowledges 
the interactions between neurons and glia in properly wiring the 
brain’s circuitry under normal physiological conditions.
Recent studies support the idea that microglial cells play a cen-
tral role in early neurodevelopment; however, the specific mecha-
nisms of how microglia contribute and what effect abnormalities 
in their contribution may have is only beginning to be under-
stood. Some have suggested that microglia may be responsible 
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for releasing trophic factors essential for early neuronal growth. 
This idea is supported by studies demonstrating that cultures 
of neuronal progenitor cells lacking microglia have decreased 
proliferation as compared to cultures containing microglia, and 
notably, this phenotype was rescued when microglia were read-
ded to the culture medium (15). Additionally, it has been shown 
that inactivating microglia in the developing mouse cortex on 
postnatal day 5 resulted in increased neuronal apoptosis in layer 
5 of the cerebral cortex (16). These studies imply that absence of 
trophic or other factors released by microglia have the potential 
to significantly alter the number of neurons within a specific brain 
region and therefore change the normal developmental trajectory 
of that region.
In addition to providing trophic support to developing neu-
rons, it has also been shown that microglial cells play a central role 
in the normal postnatal apoptosis and phagocytosis of neurons 
and their connections, which are naturally over-produced and 
then “pruned” away based on experience-dependent usage (17). 
Specifically, numerous studies over the last decade have shown 
that microglia are essential in both initiating cell death and 
phagocytizing dying neurons in the developing retina, spinal 
cord, cerebellum, hippocampus, and cerebral cortex (12, 18). It is 
not completely understood how exactly microglia carry out this 
process of cell death; however, it is thought to involve the release 
of nerve growth factors, the production of superoxide ions, 
and/or the increased expression of microglial surface proteins 
CD11b and DAP12, which initiate signal transduction leading to 
apoptosis (19). Complement activation has also been implicated 
in the mechanism of synaptic pruning in microglia (20–22). This 
idea is supported by data showing that disruption of CR3/C3 
signaling leads to increases in synapse numbers and connectivity 
(23). Interestingly, we previously found differential expression 
of DAP12 in the prefrontal cortex (PFC) of postmortem brain 
tissue from children with ASD as compared to controls (24). 
Additionally, it is known that mutations in DAP12 lead to Nasu–
Hakola disease (OMIM# 221770), a rare autosomal recessive 
disorder characterized by bone abnormalities and adult-onset 
neuropsychiatric features, such as social disinhibition, distract-
ibility, and lack of appropriate emotionality (25).
Apart from directly impacting the number of neurons in 
the developing brain, microglial cells have been shown to be 
involved in more nuanced aspects of synaptogenesis, such as in 
controlling the number of synapses, and in regulating synapse 
maturation and function (26–28). Synapse pruning is thought 
to be regulated by both spontaneous- and experience-driven 
processes, and recent studies have shown that microglia may be 
involved in both of these mechanisms. It has been shown that 
microglial cells contact dendritic spines, presynaptic terminals, 
and synaptic clefts during a critical period in the development of 
the mouse visual cortex, and additionally that the size of dendritic 
spines change after contact with microglia (29). Perhaps the most 
substantial mechanistic linkage of microglia to normal neu-
rodevelopment and behavior was a study that assessed for both 
cellular and behavioral outcomes of mice lacking the Fractalkine 
receptor CX3CR1 that is expressed exclusively on microglia 
in the CNS (26). This study showed that CX3CR1 knockout 
mice had delayed synaptic pruning, resulting in excessive and 
electrophysiologically immature synapses. Moreover, related 
studies have even suggested that the behavioral phenotype of 
these mice is altered. For instance, it was demonstrated that mice 
lacking CX3CR1 had decreased functional brain connectivity, 
deficits in synaptic pruning, and behavioral changes associated 
with the autism phenotype, such as deficits in social interaction 
and increased repetitive behaviors (30).
Microglia in asd
Although microglia’s role in normal neurodevelopment is 
beginning to be well-recognized, parallel research into the role 
of microglia in autism and other neurodevelopmental disorders 
apart from their classic inflammatory function is only in its 
infancy. However, there is a large body of literature assessing 
aberrant immune function in peripheral tissue of children with 
ASD. For instance, numerous studies have suggested the innate 
immune response is globally abnormal in autistic patients (31–
34). Specifically, peripheral blood monocytes have been shown to 
differ significantly in autistic patients. For instance, they secrete 
a cytokine pattern upon stimulation that is altered and more 
responsive to certain TLR ligands (35). Autistic patients also have 
higher plasma levels of factors involved with normal macrophage/
monocyte activation, such as macrophage inhibitory factor and 
neopterin, and some studies have shown increased absolute 
monocytes on standard complete blood count in children with 
ASD as compared to controls (36, 37). Additionally, chemokines 
were shown to be increased in the plasma of children with ASD 
compared to age-matched typically developing controls and 
children with developmental disabilities other than ASD, and 
this increased chemokine production was associated with higher 
aberrant behavior scores and more impaired developmental and 
adaptive function (33). However, only more recently have rigor-
ous assessment of microglia in postmortem brain tissue from 
patients with ASD been undertaken.
In 2005, Vargas and colleagues demonstrated that postmortem 
brain tissue from patients with autism exhibits an increased 
microglial density in gray matter and an activated microglial 
morphology; additionally, altered cytokine profiles were found 
in both ASD postmortem brain tissue and cerebrospinal fluid (7). 
Since this study, multiple other groups have reported increased 
microglial cell density in postmortem autism brains (8, 10), and 
we also reported increased numbers of microglial cell-specific 
surface markers in postmortem autism PFC as compared to 
control brains (24). Notably, the cellular volume of the activated 
microglia is two to four times the volume of quiescent microglial 
cells, and thus the increase in cell density may be partly related to 
increases in the number of activated microglia not overall micro-
glial cell number alone (8). Additionally, it has been proposed 
that an increase in activated microglia may explain the increase in 
head circumference and brain volume observed in young children 
with autism (38), although this remains controversial as does the 
finding of increased head circumference in ASD in general (39).
In addition to cell-level studies of microglia in autistic postmor-
tem brain tissue, a number of whole-genome expression studies 
have investigated RNA expression patterns in ASD postmortem 
brain tissue as compared to neurotypical controls (40–42). A 
recurrent finding in these studies is alterations in functional gene 
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ontology pathways related to the immune response. For instance, 
dysregulated levels of immune system-related genes have been 
demonstrated in multiple independent studies that have assessed 
many different brain regions (41–46). While these studies show 
that genes related to “immune” functions are aberrantly expressed 
in postmortem brain tissue from patients with ASD, they do not 
clarify whether underlying genetic variants cause this expres-
sion profile or if this pattern represents an epigenetic response 
to either endogenous or exogenous brain insults. Future work 
assessing for enrichment of genetic variants in genes exclusively 
expressed in microglia among patients with ASD would help 
answer this question and could be undertaken readily. Studies 
of epigenetic changes in individual cell types from postmortem 
autistic brain tissue may yield additional critical insight into the 
relative contribution of environmental factors on this repeatedly 
demonstrated gene expression profile.
While postmortem brain studies have begun identifying abnor-
mal microglia in ASD, by their nature, they are inherently limited 
in attempting to ascertain if abnormal microglia are a reaction to, 
or the cause of, abnormal neurodevelopment. However, recent 
studies in rodent models of autism have begun to explore this 
question in more mechanistic detail. For instance, it was found 
that microglia from MeCP2 null mice, a model of Rett syndrome, 
produced a conditioned media that damaged synaptic connectiv-
ity via a glutamate-excitotoxicity mechanism (9). Importantly, 
much of the phenotype associated with this disorder was reversed 
after transplanting wild-type microglia with a functional MeCP2 
gene, suggesting microglia play a key role in the pathogenesis of 
this disease. Moreover, it was recently demonstrated that the Rett 
phenotype may be partly related to MeCP2 direct modulation 
of microglial inflammatory gene transcription (47). Similarly, a 
large body of work has demonstrated that maternal inflammation 
during gestation may result in phenotypes similar to ASD in both 
primates and rodents (48–50). This important work begins to 
bridge the gap in understanding between inherited risk for ASD 
and environmental exposures; yet, a mechanistic understand-
ing of this work that relates to known postmortem findings in 
humans with ASD is not yet clear nor does it fully encompass 
the known genetic risk for ASD. Our hypothesis presented here 
would be further supported by these studies, in that the inherited 
risk for ASD could result in “primed” abnormal microglial cells 
that in individuals exposed to maternal inflammation or other 
factors results in an exaggerated/abnormal microglial response 
that perturbs normal neural network development (48).
Much work remains to definitively link abnormal microglia 
with the broad autistic phenotype; however, the evidence pre-
sented provides strong support to the notion that microglial cells 
may be able to reconcile the two most consistent gene expression 
and cellular findings in autism – changes in synaptogenesis and 
immune pathways. This hypothesis is particularly exciting as 
inherent “hypomorphic” abnormalities in microglia at the genetic 
or epigenetic level and their resultant impaired functioning in 
neurodevelopment may help to explain the substantial contri-
bution to autism risk that is thought to arise from interactions 
among intrinsic and environmental factors (51).
ConCLUsion
In summary, mounting evidence suggests that normal neurode-
velopment represents a complex interplay between microglial 
cells and synaptic wiring. Furthermore, non-inflammatory 
roles for microglia in normal neurodevelopment are becoming 
increasingly identified. In parallel, abnormal immune signal-
ing and microglial function are consistently demonstrated in 
postmortem tissue from autistic individuals as well as in mouse 
models of ASD. Previous research into altered immune function 
in autism has focused on the notion that microglia may cause 
destruction of already developed neural networks, perhaps in 
response to external insults, through their traditional inflam-
matory role. However, as their critical non-inflammatory role in 
normal neurodevelopmental becomes increasingly recognized, 
it is equally likely that this is what may be perturbed in ASD, 
yet was traditionally considered to be “immune dysregulation.” 
Future research should attempt to integrate the genetic and 
epigenetic etiology, neuronal synaptic disconnectivity, and 
abnormal microglia/immune findings in autism in an attempt to 
determine the precise role non-immune functions of microglia 
may play in the pathogenesis of ASD and other neurodevelop-
mental disorders.
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